One would have to say that with the share price strength we have seen the LDA put call option funding agreement arranged by the CEO is proving that the CEO and Board are serious about maximising shareholder value and restricting dilution while driving AKIDA technology towards commercial success.
Not even Covid-19 and a justified global pull back in the markets seems capable of tarnishing their success.
My opinion only DYOR.
2020 BRN Discussion, page-9013
-
- There are more pages in this discussion • 20,301 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BRN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $333.0M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 16.8¢ | $1.174M | 6.869M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 185137 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 920196 | 12 |
View Market Depth
| Last trade - 16.10pm 13/08/2024 (20 minute delay) ? |
| BRN (ASX) Chart |